Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Long-acting injectable ARVs are convenient and private, study participants report

HIV-positive people who took injectable cabotegravir + rilpivirine every four or eight weeks as antiretroviral therapy found it more convenient and discreet than daily pills, also feeling

Published
17 January 2018
By
Roger Pebody
U=U laggards draw fire from the community

The Global U=U picture is good, but community activists are stepping up the heat on organizations which have been slow to embrace it. Today the spotlight is on Greater than AIDS, GNP+ and in Canada, the Ontario AIDS Network.

Published
17 January 2018
From
Positive Lite
Drug users find safety, community in underground injection facility

Intravenous drug users who inject in a secret U.S. facility where staff provide clean needles and guard against overdoses say they appreciate the site for letting them in off the streets and for its history-shaping role.

Published
16 January 2018
From
Reuters
Study suggests many gay and bisexual men are skeptical about U=U, but attitudes are on the rise

Numerous well-controlled trials have recently demonstrated that there is effectively no risk of HIV transmission during sex with a partner who has a sustained, undetectable viral load (Undetectable = Untransmittable). The Hunter CHEST study sought to examine how accurate gay and bisexual men perceive this message to be by surveying more than 12,000 men across the United States in the summer of 2017.

Published
16 January 2018
From
EurekAlert!
My PrEP story: Phil (part 1)

My PrEP Story is the personal voice of people who are using, or have used, PrEP. Find out more about their decisions to use PrEP, how they have navigated using PrEP, and their very own PrEP journey.

Published
16 January 2018
From
PrEPster
Alberta considers funding HIV prevention drug, in what could be 'tipping point' in epidemic

After years of urging the province for changes, sexual health advocates are hopeful Alberta will finally fund an expensive drug that can prevent the spread of HIV.

Published
16 January 2018
From
CBC.ca
Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

Two new qualitative studies from Toronto shed light on how stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience of taking it. In the first,

Published
15 January 2018
By
Roger Pebody
Withdrawing Depo-Provera contraceptives would result in more lives lost than HIV infections prevented

Even if Depo-Provera and other contraceptive injections raise the risk of HIV infection, withdrawing them from use in African countries would greatly increase maternal mortality, a modelling study

Published
11 January 2018
By
Roger Pebody
'Thinking About Sex?' DC Uses Racy Ad to Promote Anti-HIV Drug

Health officials hope the provocative campaign will increase awareness of a drug that reduces the risk of HIV by over 90 percent.

Published
10 January 2018
From
NBC4 Washington
HIV spike linked to injection-drug use hits Cincinnati area

The number of HIV cases linked to injection-drug use in Northern Kentucky and Southwest Ohio increased dramatically last year, according to public health officials. Now the federal Centers for Disease Control and Prevention is assisting with genetic testing to determine if the cases are connected.

Published
10 January 2018
From
USA TODAY
← First12345...568Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.